The Sanders Tri-Institutional Therapeutics Discovery Institute and Cornell's Big Red Venture Fund present:
3rd Annual Bench to Bedside Initiative Shark Tank Pitch Day
High-profile investors will evaluate 7-minute business start-up pitches based on life science inventions from teams of scientists, physicians and young professionals from Weill Cornell Medical College, Memorial Sloan Kettering Cancer Center, and Rockefeller University.
Imran Babar, Ph.D.
Private Equity Senior Associate
OrbiMed Advisors LLC
Nicholas Bishop, Ph.D.
Colleen Cuffaro, Ph.D.
Arthur Klausner, M.B.A.
Chief Executive Officer, Gem Pharmaceuticals LLC
Chief Executive Officer, Jade Pharmaceuticals Inc.
Chairman and Chief Executive Officer
Livingston Securities LLC
Paul Maddon, M.D., Ph.D.
Progenics Pharmaceuticals Inc.
Liza Page Nelson, M.B.A.
Epigenesis Pharmaceuticals LLC
Carlo Rizzuto, Ph.D.
Principal, Biotechnology Investing
Nick Veomett, Ph.D.
McKinsey & Company
Refreshments and networking to follow.
Tickets are free, but available on a first-come, first-served basis. RSVP here
Contact firstname.lastname@example.org for additional information
Thursday, November 19, 2015 at 5:30pm
Rockefeller Research Laboratories, auditorium 430 E. 67th St